Clinical remission
Showing 1 - 25 of >10,000
Giant Cell Arteritis Trial (Secukinumab 300 mg, s.c., Placebo to match Secukinumab, s.c.)
Recruiting
- Giant Cell Arteritis
- Secukinumab 300 mg, s.c.
- Placebo to match Secukinumab, s.c.
-
Berlin, Germany
- +2 more
Oct 12, 2022
Ulcerative Colitis Trial in Naples (Filgotinib, Placebo)
Recruiting
- Ulcerative Colitis
- Filgotinib
- Placebo
-
Naples, FloridaGastroenterology Group of Naples
Aug 2, 2022
Diabetic Foot Trial in Madrid (2 weeks revision)
Not yet recruiting
- Diabetic Foot
- 2 weeks revision
-
Madrid, SpainClínica Universitaria de Podología de la Universidad Complutense
Nov 15, 2023
Rheumatoid Arthritis, JAK Inhibitor, Musculoskeletal Ultrasound Trial in Nagasaki (upadacitinib 15mg/day)
Recruiting
- Rheumatoid Arthritis
- +3 more
- upadacitinib 15mg/day
-
Nagasaki, JapanNagasaki University Hospital
Nov 24, 2021
Severe Alcoholic Hepatitis Trial in New Delhi (Prednisolone, Standard Medical therapy, Placebo)
Not yet recruiting
- Severe Alcoholic Hepatitis
- Prednisolone
- +2 more
-
New Delhi, Delhi, IndiaInstitute of Liver & Biliary Sciences (ILBS)
Dec 2, 2023
IBD Trial in Roma (Multimodal ultrasound)
Recruiting
- Inflammatory Bowel Diseases
- Multimodal ultrasound
-
Roma, ItalyFondazione Policlinico Gemelli IRCCS
Aug 3, 2023
ANCA-associated Vasculitis, Maintenance Therapy Trial in Beijing (Azathioprine, Telitacicept)
Recruiting
- ANCA-associated Vasculitis
- Maintenance Therapy
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jul 20, 2023
Rectal Cancer Trial in Taipei (Surgery)
Recruiting
- Rectal Cancer
- Surgery
-
Taipei, TaiwanJin-Tung LIANG
Jul 27, 2023
Acute Myeloid Leukemia Trial in Nanjing (Venclexta 100 MG Oral Tablet)
Recruiting
- Acute Myeloid Leukemia
- Venclexta 100 MG Oral Tablet
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital with Nanjing Medical University
Jun 11, 2023
Giant Cell Arteritis Trial in Bonn (Methotrexate, Sodium chloride)
Recruiting
- Giant Cell Arteritis
- Methotrexate
- Sodium chloride
-
Bonn, GermanyMedical Clinic and Polyclinic III Internal medicine Oncology, He
Dec 16, 2022
Residual Disease in Breast Cancer Remission After Primary
Recruiting
- Breast Cancer
- minimally invasive preoperative image-guided vacuum-assisted biopsy
-
Milan, ItalyFondazione IRCCS Istituto Nazionale dei Tumori
Jul 10, 2023
Colitis,Ulcerative Trial in Norway (Discontinuation of anti-TNF treatment, Continuation of anti-TNF treatment)
Active, not recruiting
- Colitis,Ulcerative
- Discontinuation of anti-TNF treatment
- Continuation of anti-TNF treatment
-
Alesund, Norway
- +18 more
Jul 13, 2022
Diffuse Large B-cell Lymphoma (DLBCL) Trial in Lanzhou (Zanubrutinib)
Not yet recruiting
- Diffuse Large B-cell Lymphoma (DLBCL)
-
Lanzhou, Gansu, ChinaThe First Hospital of Lanzhou University
Oct 23, 2022
Diabetes, Type 2 Trial in Jönköping, Umeå, Örnsköldsvik (Total diet replacement, eHealth, Face-to-face)
Recruiting
- Diabetes Mellitus, Type 2
- Total diet replacement
- +2 more
-
Jönköping, Sweden
- +2 more
Aug 5, 2022
Diffuse Large B-cell Lymphoma Trial in Changchun (Mitoxantrone HCl liposome injection, RiTUXimab Injection, Cyclophosphamid)
Not yet recruiting
- Diffuse Large B-cell Lymphoma
- Mitoxantrone hydrochloride liposome injection
- +4 more
-
Changchun, Jilin, ChinaThe First Bethune Hospital of Jilin University
Aug 15, 2023
Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers
Completed
- Fallopian Tube Cancer
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 7, 2022
Melanoma Trial in New York (DC Vaccine, Montanide Vaccine, Poly-ICLC)
Completed
- Melanoma
- DC Vaccine
- +2 more
-
New York, New York
- +1 more
Sep 13, 2022
Progression Free Survival, Overall Survival, Maintenance Trial (Ixazomib DX/Lenalidomide DX)
Not yet recruiting
- Progression Free Survival
- +2 more
- Ixazomib DX/Lenalidomide DX
- (no location specified)
Jul 27, 2022
Lupus Nephritis, Remission, Safety Issues Trial in Nanjing (Methylprednisolone Injectable Suspension, Belimumab Injection,
Recruiting
- Lupus Nephritis
- +2 more
- Methylprednisolone Injectable Suspension
- +2 more
-
Nanjing, Jiangsu, ChinaJiong Zhang
May 8, 2023
Endoscopic Remission, Histologic Remission and Barrier Healing
Recruiting
- Inflammatory Bowel Diseases
- Recording of major clinical events
-
Erlangen, GermanyUniversity Hospital Erlangen
Dec 14, 2021
Clinical Pathways for Newly Diagnosed Multiple Myeloma
Not yet recruiting
- Multiple Myeloma
- Multiple Myeloma Without Mention of Remission
- Multiple Myeloma Pathway
- +2 more
- (no location specified)
Nov 27, 2023
Type 2 Diabetes Trial in Umeå (Diabetes remission using total diet replacement and eHealth contact with the healthcare provider)
Completed
- Type 2 Diabetes
- Diabetes remission using total diet replacement and eHealth contact with the healthcare provider
-
Umeå, SwedenDepartment of Public Health and Clinical Medicine, Medicine
Jan 29, 2022